Intraoperative fluid management is a complicated process that cannot be standardized across all patients due to individual variability. However, a fundamental guideline applicable to everyone is the meticulous replacement of fluids being lost. This encompasses:
- Maintenance Fluids: These are administered to meet the patient's basic fluid needs, addressing both sensible losses like urine output and defecation, and insensible losses, which include evaporation through sweat, open surgical wounds, and respiratory tract losses. At the start of any procedure, it's crucial to begin with a calculated amount of maintenance fluids without attempting to correct any pre-existing fluid deficits.
- Type of Maintenance IV Fluids: For major surgeries, the consensus leans towards using isotonic, balanced crystalloids. These fluids, such as lactated Ringer’s, PlasmaLyte A, and Normosol, are preferred because their composition closely mirrors that of plasma electrolytes and maintains acid-base balance, offering a more physiologically compatible hydration solution.
- Volume Therapy: This strategy involves the administration of IV fluid boluses to evaluate and respond to volume responsiveness, aiming to rectify any signs of hypovolemia. The objective here is to enhance intravascular volume and oxygen delivery. Optimizing fluid boluses involves administering 250 mL increments and monitoring for a response. In the absence of volume responsiveness, the protocol may require the initiation of vasopressors or inotropes as necessary.
- Choice of Fluid for Volume Therapy: The debate over the optimal fluid for volume therapy—crystalloid versus colloid—continues. Goal-directed therapy protocols have predominantly utilized colloid boluses for this purpose. Despite a few small-scale studies suggesting that colloid-based resuscitation may reduce the total volume of IV fluids required (with a ratio of around 1.6:1 compared to crystalloids), no significant differences in clinical outcomes have been conclusively demonstrated.
Reflecting on the findings from the RELIEF trial and other research, the prevailing recommendation for fluid management in major surgery has shifted towards a moderately liberal approach. This strategy balances the need to prevent hypovolemia and its associated risks with the goal of avoiding the complications tied to excessive fluid administration, thus ensuring optimal patient outcomes during and after surgery.
